Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Proteomics01:33

Proteomics

A proteome is the entire set of proteins that a cell type produces. We can study proteomes using the knowledge of genomes because genes code for mRNAs, and the mRNAs encode proteins. Although mRNA analysis is a step in the right direction, not all mRNAs are translated into proteins.
Proteomics is the study of proteomes' function. It involves the large-scale systematic study of the proteome to denote the protein complement expressed by a genome. Scientist Mark Wilkins coined the term proteomics...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Acquired genetic and cell-state changes in IDH-mutant glioma progression.

Nature·2026
Same author

CDK12/CDK13 inhibition disrupts transcriptional elongation and replication fork progression in glioblastoma.

EMBO molecular medicine·2026
Same author

Modelling brain tumours with organoids: towards precision medicine in neuro-oncology.

Nature reviews. Neurology·2026
Same author

Steroid-dependent metabolic rewiring reveals novel therapeutic and imaging approaches for glioblastoma.

Science advances·2026
Same author

Development of a highly differentiated rat brain organoid model for exploring glioblastoma invasion dynamics and therapy.

Neuro-oncology·2025
Same author

Towards fair decentralized benchmarking of healthcare AI algorithms with the Federated Tumor Segmentation (FeTS) challenge.

Nature communications·2025

Related Experiment Video

Updated: Jun 14, 2026

Preparation Of Neovascular Tissues from Human Glioma Tissues for Quantitative Proteomics Analysis of Tumor Angiogenesis
09:33

Preparation Of Neovascular Tissues from Human Glioma Tissues for Quantitative Proteomics Analysis of Tumor Angiogenesis

Published on: March 20, 2026

Glioma proteomics: status and perspectives.

Simone P Niclou1, Fred Fack, Uros Rajcevic

  • 1Norlux Neuro-Oncology Laboratory, Department of Oncology, Centre de Recherche Public de la Santé (CRP-Santé), Luxembourg, Luxembourg. simone.niclou@crp-sante.lu

Journal of Proteomics
|March 25, 2010
PubMed
Summary

High grade gliomas are a major cause of cancer death. Proteomics research is crucial for identifying new drug targets and biomarkers to improve diagnosis and treatment for these aggressive brain tumors.

More Related Videos

On-Site Sampling and Extraction of Brain Tumors for Metabolomics and Lipidomics Analysis
06:48

On-Site Sampling and Extraction of Brain Tumors for Metabolomics and Lipidomics Analysis

Published on: May 31, 2020

Digital Spatial Profiling for Characterization of the Microenvironment in Adult-Type Diffusely Infiltrating Glioma
09:17

Digital Spatial Profiling for Characterization of the Microenvironment in Adult-Type Diffusely Infiltrating Glioma

Published on: September 13, 2022

Related Experiment Videos

Last Updated: Jun 14, 2026

Preparation Of Neovascular Tissues from Human Glioma Tissues for Quantitative Proteomics Analysis of Tumor Angiogenesis
09:33

Preparation Of Neovascular Tissues from Human Glioma Tissues for Quantitative Proteomics Analysis of Tumor Angiogenesis

Published on: March 20, 2026

On-Site Sampling and Extraction of Brain Tumors for Metabolomics and Lipidomics Analysis
06:48

On-Site Sampling and Extraction of Brain Tumors for Metabolomics and Lipidomics Analysis

Published on: May 31, 2020

Digital Spatial Profiling for Characterization of the Microenvironment in Adult-Type Diffusely Infiltrating Glioma
09:17

Digital Spatial Profiling for Characterization of the Microenvironment in Adult-Type Diffusely Infiltrating Glioma

Published on: September 13, 2022

Area of Science:

  • Neuro-oncology
  • Proteomics
  • Cancer Research

Background:

  • High grade gliomas are the most common adult brain tumors and the fourth leading cause of cancer mortality.
  • Significant advancements in treating other cancers highlight the need for improved neuro-oncology research and treatment efficacy for gliomas.
  • Identifying novel drug targets and specific protein signatures is essential for better diagnosis, prognosis, and treatment strategies for gliomas.

Purpose of the Study:

  • To provide an extensive review of glioma proteomics studies.
  • To analyze protein identifications, including protein numbers and regulated proteins from various glioma models.
  • To emphasize the methods, limitations, and potential of proteomics in biomarker discovery for high grade gliomas.

Main Methods:

  • Review of published glioma proteomics studies.
  • Analysis of proteome data from patient biopsies, bodily fluids, cell lines, and animal models.
  • Evaluation of protein identification data and methodologies employed.

Main Results:

  • Summarizes protein identification outcomes from diverse glioma research levels.
  • Highlights the methods utilized in past and current glioma proteomics investigations.
  • Discusses the limitations encountered in proteomic studies concerning biomarker discovery.

Conclusions:

  • Proteomics offers significant potential for understanding glioma biology and improving patient outcomes.
  • Further research and novel technologies are needed to fully leverage proteomics for glioma biomarker discovery and therapeutic development.
  • The review underscores the importance of proteomics in advancing neuro-oncology and addressing the challenges posed by high grade gliomas.